Search research articles
Contact Us
Filters
Showing results (191-200 of 213) with videos related to
Page
of 22
Sort By:
European Journal of Heart Failure
|
April 13, 2021
Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE-MI): design and baseline characteristics
Karola S Jering, Brian Claggett, Marc A Pfeffer, et al.
Circulation
|
November 2, 2022
The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial
Roxana Mehran, Philippe Gabriel Steg, Marc A Pfeffer, et al.
JACC. Heart Failure
|
December 1, 2022
Functional and Symptomatic Clinical Trial Endpoints: The HFC-ARC Scientific Expert Panel
Mitchell A Psotka, William T Abraham, Mona Fiuzat, et al.
American Heart Journal
|
November 27, 2019
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure: Rationale and design of CONNECT-HF
Adam D DeVore, Bradi B Granger, Gregg C Fonarow, et al.
JACC. Heart Failure
|
July 15, 2019
Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial
Alvin Chandra, Muthiah Vaduganathan, Eldrin F Lewis, et al.
European Journal of Heart Failure
|
April 12, 2023
Geographic differences in patients with acute myocardial infarction in the PARADISE-MI trial
Jawad H Butt, Brian L Claggett, Zi M Miao, et al.
The New England Journal of Medicine
|
April 29, 2021
Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis
Kai-Uwe Eckardt, Rajiv Agarwal, Ahmad Aswad, et al.
Journal of the American College of Cardiology
|
November 13, 2020
Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert Panel
Mitchell A Psotka, William T Abraham, Mona Fiuzat, et al.
European Journal of Heart Failure
|
September 29, 2025
Blood pressure, safety and clinical efficacy of vericiguat in chronic heart failure with reduced ejection fraction: Insights from the VICTOR trial
Robert J Mentz, Javed Butler, Ciaran J McMullan, et al.
Journal of the American College of Cardiology
|
September 2, 2025
Effect of Vericiguat on Worsening Heart Failure in Compensated Outpatients with HFrEF: Insights from VICTOR
Faiez Zannad, Yogesh N V Reddy, Irina Barash, et al.
Page
of 22
Search research articles
Search
Showing results (191-200 of 213) with videos related to
Sort By:
Page
of 22
European Journal of Heart Failure
|
April 13, 2021
Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE-MI): design and baseline characteristics
Karola S Jering, Brian Claggett, Marc A Pfeffer, et al.
Circulation
|
November 2, 2022
The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial
Roxana Mehran, Philippe Gabriel Steg, Marc A Pfeffer, et al.
JACC. Heart Failure
|
December 1, 2022
Functional and Symptomatic Clinical Trial Endpoints: The HFC-ARC Scientific Expert Panel
Mitchell A Psotka, William T Abraham, Mona Fiuzat, et al.
American Heart Journal
|
November 27, 2019
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure: Rationale and design of CONNECT-HF
Adam D DeVore, Bradi B Granger, Gregg C Fonarow, et al.
JACC. Heart Failure
|
July 15, 2019
Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial
Alvin Chandra, Muthiah Vaduganathan, Eldrin F Lewis, et al.
European Journal of Heart Failure
|
April 12, 2023
Geographic differences in patients with acute myocardial infarction in the PARADISE-MI trial
Jawad H Butt, Brian L Claggett, Zi M Miao, et al.
The New England Journal of Medicine
|
April 29, 2021
Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis
Kai-Uwe Eckardt, Rajiv Agarwal, Ahmad Aswad, et al.
Journal of the American College of Cardiology
|
November 13, 2020
Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert Panel
Mitchell A Psotka, William T Abraham, Mona Fiuzat, et al.
European Journal of Heart Failure
|
September 29, 2025
Blood pressure, safety and clinical efficacy of vericiguat in chronic heart failure with reduced ejection fraction: Insights from the VICTOR trial
Robert J Mentz, Javed Butler, Ciaran J McMullan, et al.
Journal of the American College of Cardiology
|
September 2, 2025
Effect of Vericiguat on Worsening Heart Failure in Compensated Outpatients with HFrEF: Insights from VICTOR
Faiez Zannad, Yogesh N V Reddy, Irina Barash, et al.
Page
of 22